Serveur d'exploration sur la maladie de Parkinson - Exploration (Accueil)

Index « Keywords » - entrée « Dopamine »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopac < Dopamine < Dopamine Agonist  Facettes :

List of bibliographic references indexed by Dopamine

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
001995 (2001) Marina E. Emborg [États-Unis] ; Nicole Deglon [Suisse] ; Liza Leventhal [États-Unis] ; Patrick Aebischer [Suisse] ; Jeffrey H. Kordower [États-Unis]Viral vector-mediated gene therapy for Parkinson's disease
001997 (2001) J. N. Joyce [États-Unis] ; H. Ryoo [États-Unis] ; E. V. Gurevich [États-Unis] ; C. Adler [États-Unis] ; T. Beach [États-Unis]Ventral striatal D3 receptors and Parkinson's Disease
001A04 (2001) Stéphane Hunot [France] ; Andreas Hartmann [France] ; Etienne C. Hirsch [France]The inflammatory response in the Parkinson brain
001A46 (2001) Claudio Da Cunha [Brésil] ; Monique S. Gevaerd [Brésil] ; Maria Aparecida B. F Vital [Brésil] ; Edmar Miyoshi [Brésil] ; Roberto Andreatini [Brésil] ; Rodolfo Silveira [Brésil] ; Reinaldo N. Takahashi [Brésil] ; Newton S. Canteras [Brésil]Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia
001A84 (2001) Masashi Kitazawa [États-Unis] ; Vellareddy Anantharam [États-Unis] ; Anumantha G. Kanthasamy [États-Unis]Dieldrin-induced oxidative stress and neurochemical changes contribute to apoptopic cell death in dopaminergic cells
001C24 (2000) H. M Schipper [Canada]Heme oxygenase-1: role in brain aging and neurodegeneration
001D20 (1999) Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]Treatment of Parkinson's disease should begin with a dopamine agonist
001E08 (1999) Rowena E. Johnston [États-Unis] ; Jill B. Becker [États-Unis]Behavioral changes associated with grafts of embryonic ventral mesencephalon tissue into the striatum and/or substantia nigra in a rat model of Parkinson’s Disease
002009 (1997) Anumantha G. Kanthasamy [États-Unis] ; Arthi Kanthasamy [États-Unis] ; Rae R. Matsumoto [États-Unis] ; Toan Q. Vu [États-Unis] ; Daniel D. Truong [États-Unis]Neuroprotective effects of the strychnine-insensitive glycine site NMDA antagonist ( R )-HA-966 in an experimental model of Parkinson's disease
002140 (1996) Michael S. Cousins [États-Unis] ; John D. Salamone [États-Unis]Skilled motor deficits in rats induced by ventrolateral striatal dopamine depletions: behavioral and pharmacological characterization
002212 (1996) Manfred Gerlach [Allemagne] ; Wieland Gsell [Allemagne] ; Johannes Kornhuber [Allemagne] ; Kurt Jellinger [Autriche] ; Verena Krieger [Autriche] ; Felix Pantucek [Autriche] ; Reinhard Vock [Allemagne] ; Peter Riederer [Allemagne]A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome
002283 (1995) F. Thibaut [France] ; B. A. Faucheux [France] ; J. Marquez [France] ; J. Villares [France] ; J. F. Menard [France] ; Yves Agid [France] ; E. C. Hirsch [France]Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine
002337 (1995) Irit Gordon [Israël] ; Ronit Weizman [Israël] ; Ella Rosenne [Israël] ; Moshe Rehavi [Israël]Developmental and age-related alterations in rat brain presynaptic dopaminergic mechanisms
002346 (1995) A. Espino [Espagne] ; J. Llorens [Espagne] ; M. Calopa [Espagne] ; R. Bartrons [Espagne] ; E. Rodriguez-Farre [Espagne] ; S. Ambrosio [Espagne]Cerebrospinal dopamine metabolites in rats after intrastriatal administration of 6-hydroxydopamine or 1-methyl-4-phenylpyridinium ion
002419 (1994) K. Shannak ; A. Rajput [Canada] ; B. Rozdilsky [Canada] ; S. Kish ; J. Gilbert [Canada] ; O. HornykiewiczNoradrenaline, dopamine and serotonin levels and metabolism in the human hypothalamus: observations in Parkinson's disease and normal subjects
002424 (1994) Stéphane Lehéricy [France] ; Jean-Philippe Brandel [France] ; Etienne C. Hirsch [France] ; Philippe Anglade [France] ; Joao Villares [France] ; Daniel Scherman [France] ; Charles Duyckaerts [France] ; France Javoy-Agid [France] ; Yves Agid [France]Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography
002442 (1994) H. Ikeda [Royaume-Uni] ; G. M. Head [Royaume-Uni] ; C. J K. Ellis [Royaume-Uni]Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson's disease and a follow up study
002563 (1993) Ruey-Meei Wu [Taïwan, États-Unis] ; Chuang C. Chiueh [États-Unis] ; Agu Pert [États-Unis] ; Dennis L. Murphy [États-Unis]Apparent antioxidant effect of l-deprenyl on hydroxyl radical formation and nigral injury elicited by MPP+ in vivo
002653 (1992) Dwaine F. Emerich [États-Unis] ; Shelley R. Winn [États-Unis] ; Lisa Christenson [États-Unis] ; Meg A. Palmatier [États-Unis] ; Frank T. Gentile [États-Unis] ; Paul R. Sanberg [États-Unis]A novel approach to neural transplantation in Parkinson's disease: Use of polymer-encapsulated cell therapy
002784 (1990) J. S. Schneider [États-Unis] ; C. J. Kovelowski Ii [États-Unis]Chronic exposure to low doses of MPTP. I. Cognitive deficits in motor asymptomatic monkeys
002A04 (1985) S. Kaakkola [Finlande] ; P. T. M Nnistö [Finlande] ; E. Nissinen [Finlande] ; A. Vuorela [Finlande] ; R. M Ntyl [Finlande]The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopamine" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024